Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-303910

Chief Operating Officer sold 5,000 shares at $30.10 ($150,487)

  • Chief Operating Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2025-11-26 Option exercise 10b5-1 +5,000 $1.80 $9,000 176,928 D: show line 1 in the form
Gault Cheryl Chief Operating Officer 2025-11-26 Sale 10b5-1 −5,000 $30.10 $150,487 171,928 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $30.10 · $150,487

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2025-11-26 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 105,407 D: show line 3 in the form
Loading xslF345X05/ownership.xml…